Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Jason Rando - EVP & COO, Tiberend Strategic Advisors, Inc., IR David Arthur - President and CEO Mark Rosenblum - CFO Daniela Santiesteban - Director of Business Development and Research Conference Call Participants Hunter Diamond - Diamond Equity Research LLC Wangzhi Li - Ladenburg Thalmann & Co. Inc Operator Ladies and gentlemen, thank you for standing by, and welcome to the Q1, 2020 S ...

Company Overview 1Q 2020 © 2020 Salarius Pharmaceuticals, Inc. Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement in this presentation that is not a historical fact is a forward-looking statement. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performa ...